Waldencast plc (WALD)

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Waldencast plc (“Waldencast” or “the Company”) (NASDAQ: WALD, WALDW). Investors who purchased Waldencast securities are encouraged to obtain additional information and assist the investigation.

The investigation concerns whether Waldencast has violated federal securities laws. 

Investigation Details: 

On July 5, 2023, Waldencast disclosed that certain previously issued financial statements of Obagi Global Holdings Limited (“Obagi”) should no longer be relied upon because the Company discovered errors related to revenue recognition in connection with Obagi’s sales activity to its Southeast Asia distributor during the second half of fiscal year 2022 and marketing and other services purportedly performed by certain of Obagi’s distributors. 

On this news, Waldencast’s stock price fell $0.76, or 10.2%, to close at $6.63 on July 6, 2023, thereby injuring investors. 

What’s Next? 

If you are aware of any facts relating to this investigation or purchased Waldencast securities, you can assist this investigation. You can also contact Peretz Bronstein or his law clerk and client relations manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660.   

Why Bronstein, Gewirtz & Grossman: 

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits.  Our firm has recovered hundreds of millions of dollars for investors nationwide.  

Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Nathanson
212-697-6484 | [email protected]